Results 121 to 130 of about 10,664 (186)

Integrative Computational Prediction Strategy for Antibody-Antigen Binding: A Case Study on Interleukin-1 Beta. [PDF]

J Chem Inf Model
Aygen ME, Uyar A.
europepmc   +1 more source

Cross-national biologic treatment guidelines for FMF: a comparative analysis. [PDF]

Rheumatology (Oxford)
Kasap Cuceoglu M, Hinze T, Wittkowski H, Haslak F, Mamutova A, Oner N, Caorsi R, Bourguiba R, Elhani I, Delplanque M, El Moussaoui M, Pateras K, Sestan M, Kirijas M, Constantin T, Ducharme-Benard S, Lanchmann H, Butbul Aviel Y, Hentgen V.   +18 more
europepmc   +1 more source

Marked regression of calcinosis with canakinumab in hyperphosphatemic familial tumoral calcinosis. [PDF]

JBMR Plus
Dauchez A, Herrou J, Mihoubi-Bouvier F, Quartier P, Baujat G, Koumakis E, Briot K, Roux C.   +7 more
europepmc   +1 more source

Safety and Effectiveness of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan: A Post-Marketing Surveillance Study. [PDF]

Rheumatol Ther
Akita F, Seko N, Yoneda T.
europepmc   +1 more source

Idiopathic recurrent pericarditis in children: a tertiary care cohort highlighting the emergence and effectiveness of interleukin-1 blockade. [PDF]

Eur J Pediatr
Gunalp A, Akay N, Kirali M, Torunoglu Z, Aslan E, Gul U, Konte EK, Senturk NGK, Yildiz M, Haslak F, Adrovic A, Sahin S, Barut K, Dedeoglu R, Kasapcopur O.   +14 more
europepmc   +1 more source

Evaluation of the Effect of IL-1 Antagonists on Pituitary Function. [PDF]

Int J Endocrinol
Aktas Koc F, Sariakcali B, Sahin A.
europepmc   +1 more source

Difficult-to-Treat Rheumatoid Arthritis With Concomitant Yao Syndrome With Response to Dual-Inhibitor Therapy. [PDF]

ACR Open Rheumatol
Aljundi N, Piranavan P.
europepmc   +1 more source

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study. [PDF]

Arthritis Rheumatol
Eviatar T, Capelusnik D, Campochiaro C, Lacombe V, Jachiet V, Zisapel M, Sagy I, Tayer-Shifman OE, Ozeri D, Kivity S, Tomelleri A, Terrier B, Peleg H, Comont T, Sacre K, Woaye-Hune P, Arnaud L, Lazaro E, Grobost V, Lifermann F, Samson M, Ardois S, Garnier A, Maria A, Cantagrel A, Meyer A, Bouaziz JD, Heiblig M, Dagna L, Diral E, Kosmider O, Elkayam O, Hadjadj J, Georgin-Lavialle S, Fain O, Mekinian A.   +35 more
europepmc   +1 more source

The promise of IL-1β modulation in NSCLC clinical context. [PDF]

Front Immunol
Ghiringhelli F, Rébé C.
europepmc   +1 more source

Genotype-phenotype correlations in pediatric CAPS with predominantly low-penetrance NLRP3 variants among Turkish patients in Germany and Turkey: beyond borders. [PDF]

Pediatr Rheumatol Online J
Bayindir Y, Satirer Ö, Cam V, Turkmen S, Sozeri B, Kuemmerle-Deschner JB, Ozen S.   +6 more
europepmc   +1 more source